Nan Fung
VC Fund
Central, Hong Kong
Nan Fung is a Hong Kong-based company focused on global equities and fixed income, alternative, and strategic investments.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Nan Fung invests in
Stages Nan Fung invests in
Countries Nan Fung invests in
Investment Focus
Industry
- Health Care 2 (67%)
- Medical Device 2 (67%)
- Logistics 1 (33%)
- E-Commerce 1 (33%)
- Warehousing 1 (33%)
Stage
- Series B 2 (67%)
- Venture - Series Unknown 1 (33%)
Country
- Canada 1 (33%)
- Hong Kong 1 (33%)
- United States 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Boxful is more than just storage. They are about creating a lifestyle where space isn’t a luxury – it’s flexible and right at your fingertips. Boxful was founded on the belief that storage should be simple, affordable, and secure.They created a service that allows you to store and seamlessly manage your belongings from your computer or mobiledevice, and know that they’re just a speedy delivery away. Your home is for living and they give you the freedom to de-clutter while keeping the things that matter. | $18M / Series B / Dec 06, 2017 | ||
| Angiotech is a Vancouver, British Columbia pharmaceutical company. Its products enhance the performance of medical devices and biomaterials through the use of pharmacotherapeutics. Angiotech is a global specialty pharmaceutical and medical device company that discovers, develops, and markets innovative technologies and medical products primarilyfor local diseases or for complications associated with medical device implants, surgical interventions and acute injury. | Venture - Series Unknown / Mar 21, 2017 | ||
| We have developed a high-sensitivity next-generation sequencing-based system for the the detection of cancer mutations in miniscule concentrations of circulating cell-free DNA (cfDNA) in blood.Our technology addresses the significant barriers associated with harnessing the information contained in cfDNA by combining our proprietary techniques inmolecular biology and computational algorithm for error suppression. With our technology, nanogram quantities of highly-fragmented cfDNA can be amplified more than 1000-fold, and a panel of tens to hundreds of cancer-related genes can be screened with a sensitivity at the single-digit molecular level. | $40M / Series B / Jun 01, 2016 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Nan Fung invest in?
Nan Fung invests primarily in Health Care, Medical Device and Logistics startups, most often at Series B and Venture - Series Unknown stage. Most of the 3 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Nan Fung last invest?
The most recent investment recorded for Nan Fung closed in Dec 2017. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
